课题基金 / 基金详情

The role of opioid peptides in eating behaviours and obesity

The role of opioid peptides in eating behaviours and obesity
阿片肽在饮食行为和肥胖中的作用
批准号:
252834871
负责人:
Professor Dr. Andreas Zimmer
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2014
资助国家:
德国
项目状态:
已结题
起止时间:
2013-12-31 至 2018-12-31

项目摘要

项目成果

Professor Dr. Andreas Zimmer的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Numerous demographic reports over the last two decades described a worldwide increase in the percentage of obese and overweight people and, consequently, a tremendous rise of obesity-related health problems. The problem is still increasing, even though many overweight individuals attempt to control their diet in view of the adverse health consequences and also because most people consider a lean and fit body to be more desirable. Many investigators have noted commonalities between an uncontrolled intake of food and drug addiction, including specific behaviours, neuronal circuits and neurotransmitter systems. Most importantly, the loss of control over eating behaviours and a compulsive food intake observed in some obese individuals bears a resemblance to compulsive drug taking behaviours in people suffering from drug dependence. Several neurotransmitter and neuromodulatory systems have been described that are critically involved in these processes, such as the dopaminergic system, the endocannabinoid system, or the opioid system. The focus of this proposal is on the endogenous opioid system, which is a critical regulator of hedonic responses. The involvement of the opioid peptides in food preference and in the executive control of eating behaviour was shown in some studies, but the exact mechanisms underlying these observations are still discussed. Thus, human and animal studies for example revealed that impulsivity is associated with opiate addiction, but it is not entirely clear if this is cause or consequence of the addiction process. Similarly, executive control dysfunctions have also been implicated in eating disorders, such as anorexia and bulimia nervosa, as well as obesity. In previous studies we investigated the function of opioid peptides in the modulation of animal behaviours. We generated mice deficient for the opioid peptides enkephalin and dynorphin showed that these peptides have a profound effect on drug reward and addiction, emotionality, stress-responses and nociception. The main hypothesis of this proposal is that a prolonged voluntary consumption of high caloric palatable food, leading to obesity, produces alterations in opioid signalling. These alterations in turn impact on hedonic aspects and executive control of food intake. To test this hypothesis we will use a combination of behavioural and molecular studies in animals with genetically disrupted opioid signalling. We aim to clarify the role of specific components of the endogenous opioid system in the regulation of food intake in lean and obese subjects. A particular emphasis will be placed on obesity-induced changes in the incentive salience of food rewards and executive control functions.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/s41598-020-60518-0
发表时间: 2020-03-02
期刊: SCIENTIFIC REPORTS
影响因子: 4.6
作者: [Ghule, Aishwarya, Racz, Ildiko, Zimmer, Andreas]
通讯作者: Zimmer, Andreas
Cellular origin and function of brain 2-arachidonoylglycerol
  • 批准号:
    324087152
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2016
  • 负责人:
    Professor Dr. Andreas Zimmer
  • 依托单位:
Schizophrenia and Nicotine Addiction: Analysis of genetic mouse models
  • 批准号:
    146395062
  • 项目类别:
    Priority Programmes
  • 资助金额:
    $0.0万
  • 财政年份:
    2009
  • 负责人:
    Professor Dr. Andreas Zimmer
  • 依托单位:
The role of the CB2 receptor and human CB2 receptor variants in neuropathic pain
  • 批准号:
    62850903
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Professor Dr. Andreas Zimmer
  • 依托单位:
Common resources of the research unit
  • 批准号:
    62953203
  • 项目类别:
    Research Units
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Professor Dr. Andreas Zimmer
  • 依托单位:
国内基金
海外基金
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
  • 批准号:
    82371224
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马柯
  • 依托单位: